Page 26 - Aesthetics&Dermatology_11_2018
P. 26

RESEARCH REPORTS



        AI HOLDS GREAT PROMISE


        FOR VISUAL FIELDS LIKE


        DERMATOLOGY, BUT FACES


        MANY CHALLENGES




        Finding robust data sources, correcting for variations in images and avoiding bias are all
        hurdles to overcome.

        Computer vision has great promise
        for helping to democratize fields like
        wound care, dermatology and more.
        However, as companies explore this
        potential, they’re also discovering a
        number of challenges to overcome.
                                                              What most researchers and
        The data problem                                     developers want is an AI that
                                                           can look at pictures taken with a
        “Getting the data is really the                  smartphone in a home environment.
        biggest challenge, not the AI,”
        Karen Panetta, IEEE fellow and
        dean of graduate engineering
        at Tufts University who studies
        AI use cases in healthcare, told
        MobiHealthNews in an interview
        earlier this year. “We’ve already
        got the models, we just need
        more training data to validate this   at Mount Sinai Medical Center in   that’s problematic, right? … The
        expertise. And then, again, getting   New York, but she’s also working   whole point of a classifier is to be
        doctors to also validate, to get     remotely with teledermatology       generalizable across a population,
        random things from a cellphone,      company First Derm on improving     and you’re limited to a small amount
        and you want multiple doctors to do   the company’s AI algorithms. She   of data, that already is an issue
        it because they have to agree.”      says a traditional clinical research   from a statistical standpoint.”
                                             approach doesn’t bring in anything
        There are existing clinical data     near the scale needed for machine   This is leading a number of
        sets, but the pictures they contain   learning.                          companies like First Derm to create
        are clinical images, taken in                                            direct-to-consumer teledermatology
        controlled conditions, often with a   “The issue in general is that a    or dermatology triage tools, in which
        dermascope, which is a specialized   lot of the data people are pulling   patients consent to sharing their
        medical instrument for taking        in from healthcare studies, the     data in exchange for free access.
        pictures of the skin.                enrollment process for clinical trials
                                             is generally very slow, and very    Even companies like VisualDx,
        Furthermore, getting access to       manual. Not that this is specific to   which have a robust dataset
        medical datasets is very difficult,   any one institution, but if you have   from years in the CDS space,
        since patients have to have          sample sizes in the low hundreds    have to balance patient privacy
        consented to have their data used    or not even 100 — and there are     considerations.
        in research and most have not.       plenty of studies that are 30, 50,
        Even if they have, the researchers   70 participants, just because it’s   “In our professional tool, when a
        have to secure IRB approval for      so difficult to get a willing cohort   doctor takes a picture of a patient
        access to the images.                that will show up for all the testing   the image is analyzed on the phone
                                             you need, and generally you do      and the image is dumped,” CEO Art
        Mary Sun is a medical student        recruitment locally so it’s just the
        at the Icahn School of Medicine      patient population that’s available to                        27
                                             you and so on and so forth— and



         26
   21   22   23   24   25   26   27   28   29   30   31